DDL 2026

Nemera will attend DDL - Drug Delivery to the Lungs 2026. The event will take place on December 9-11, 2026, at Edinburgh International Conference Centre, Edinburgh, Scotland.

The Drug Delivery to the Lungs conference (DDL) is the premier conference and industry exhibition which is dedicated to pulmonary and nasal drug delivery. The focus is on providing a forum to present through podium and poster presentations recent developments in the field of inhalation therapy.

The three-day conference consists of a programme of lectures covering five session themes. Each year the DDL Committee invite a long serving respiratory health professional to deliver the commemorative DDL Lecture as a way of recognising their significant scientific accomplishments achieved in respiratory health.

As a world-leading drug delivery device solutions provider, Nemera is pleased to be an exhibitor aof the conference. This is a great opportunity to leverage our work in the inhalation and nasal categories, connect with our customers and industry peers and gather learnings on how to enhance the products and services we offer our customers and ultimately patients.

Please come by and discover our poster : Targeting the Olfactory Region: A Formative User Study Using an Average-Geometry Nasal Cast and Human Head Model

Visit us at Booth 211 to meet our team and learn more about our end-to-end capabilities in the design, development, and manufacturing of innovative nasal drug delivery devices.